IN a previous communication Sahasrabudhe (1958) put forth evidence in support of existence of a chemical competition between nucleic acid and py-ridine nucleotide syntheses for the appropriation of a common precursor, adenine. In a rapidly growing malignant tissue, adenine was shown to be appropriated for nucleic acid synthesis and very little was left for incorporation in pyridine nucleotides (Narurkar, Kumta and Sahasrabudhe, 1957). It was further show-n that the pyridine nucleotide levels were invariably lowered in presence of rapid nucleic acid synthesis irrespective of whether it (the nucleic acid synthesis) was of neoplastic or non-neoplastic origin (Jedeikin, Thomas and Weinhouse, 1956 ; Kotnis, Narurkar and Sahasrabudhe, 1959). Pyridine nucleotides have an important role in the hydrogen transport system and thus indirectly participate in the production of energy, via the tricarboxylic acid cycle. In view of this it was suggested that low levels of pyridine nucleotides automatically slow down all the synthetic and proliferative activities by controlling the energy production. Based on these ideas, a biological feed-back mechanism was postulated for the regulation of normal growth processes (Sahasrabudhe, 1958) . In'tumour tissue however, this feed-back-mechanism seems to break down; the tumour apparently is able to obtain an unhmited supply of energy to maintain its rapid nucleic acid synthesis. A search for an alternate pathway capable of producing energy independent of the proposed feed-back-mechanism revealed that hexose-monophosphate pathway (HMP) has the requisite potentiality of not only producing energy (though not yet definitely established) but also yielding ribose-5-phosphate which is the starting material for the biosynthesis of purines. In the light of this the reported preponderance of HMP pathway in tumour tissue acquires greater significance (Kit, 1956; Kit and Graham, 1956; van Vals, Bosch and Emmelot, 1956). Interference of HMP pathway, it was thought, would inhibit the tumour growth by curtailing the supply of energy and ribose-5-phosphate. This has been attempted by preparing anti-metabolites against some suitable intermediates of the HMP pathway.
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An ideal chemotherapeutic substance has to have prefere'ntial action on tumours only, with no or minimuni action on the host tissues. It was this consideration which prompted us to rule out the possibility of useful results with anti-meta-bolites of glucose-6-phosphate and fructose-6-phosphate (Sahasrabudhe, 1958 (Fieser and Fieser, 1960) prompted us to suggest that furans, tetrahydrofurans and also thiophenes and tetrahydrothiophene derivatives of type (1), JI), (111) and (IV) might inhibit malignant growth through interference of HMP. It may not be out of place to mention here that 5-hydroxy methyl-2-furfuraldehyde (Heaton and Robinson, 1948) and 5-nitro-2-furfuraldehyde (Friedgood and Green, 1950) Kornfeld and Jones, 1954) . Among the different methods available for synthesis of thiophene-2 : 5-dicarboxylic acid the two most convenient appear to be the following :-Method I.-Thiophene--*2: 5-dichloromethylthiophene-->2: 5-diacetoxymethythiophene->Thiophene-2: 5-dicarboxylic acid (TDA).
Method 2.-Thiophene--->2: 5-diiodothiophene--*2: 5-dilithium derivative--->-TDA.
In the present investigation thiophene-2: 5-dicarboxylic acid was prepared by the second method. The yields by the first method were never more than 21 per cent or so, whereas by the second method the yield was 74 (Minnis, 1943; m.p. 40-41') .
Preparation of phenyllithium (Evans and Allen, 1943) A (Wenner and Weinhouse, 1956 ):-Potassium fumarate 7 X 10-5M ; cytochrome C 4 x 1 0-1m ; DPN 2 x 10-3m ; phosphate buffer (pH 7-4) 6-0 X 10-3m; MgSO4 3 X 10-3M; KCI 1-4 x 10-1m; glucose 0-020 m and glucose-1_14C or glucose-6-14C (as the case may be) equivalent to 6-42 X 104 CpM. 1 mg. of thiophene 2, 5-dicarboxylic acid dissolved in 0-5 c.c. of 0-5 per cent NaHC03was added to the medium. A rolled filter paper soaked in 0-2 ml. 10 N NaOH was placed in the central well of Warburg flasks to absorb the C02 released. 0-3 ml. 50 per cent trichloroacetic acid was placed in the side arm. The flasks were attached to manometers and the assembly shaken for 4 hours. At the end of this period, trichloroacetic acid was tipped in the reaction vessels to stop the reaction and to li 'berate C02 from the incubation medium. Table IV . But when the frequency and the daily dose was increased, significant inhibition of tumour growth was evident in the TDA treated animals. Thus whereas the mean weight of the tumour in the control animals was 8-0 g. that of the treated groups was 3-0 g. This is clearly seen in the photographs of the treated and untreated animals ( Fig. I and 2 ). In the in vitro studies with glucose-1_14 C and glucose-6-14C it was seen that liberation of radioactive 14CO2 from glucose-1_14C was diminished in presence of TDA suggesting that the HMP was probably inhibited by the presence of TDA.
It will be noticed that in the presence of TDA the liberation of radioactive 14CO 2 from glucose-6-14C substrate was also diminished. This is due to the fact that in tumour tissue a portion of trioses is obtained via the HMP pathway. If this is so then the diminution in the evolution of radioactive C02 when glucose-6-14C is used is to be expected. In vitro studies thus seem to justify the premise that TDA or similar substances would inhibit the HMP pathway and thus bring about inhibition of tumour growth.
SUMMARY
Inhibition of tumour growth with anti-metabolites of hexose-mono-phosphate (HMP) intermediates has been attempted. Thiophene 2 : 5-dicarboxylic acid (TDA) has been synthesized and its tumour inhibiting properties have been investigated on Yoshida (ascites) sarcoma in rats and on transplantable solid fibrosarcoma in Swiss mice. The survival of Yoshida sarcoma bearing rats was increased with TDA treatment, whereas with the solid fibrosarcoma a significant inhibition of tumour growth was evident. In vitro studies carried out with glucose-1-14C and glucose-6-14C suggest that TDA interferes with the HMP pathway.
